During the past decade, Universitaetsklinikum Bonn, Immunologische Ambulanz HIV conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV" are "HIV Coinfection" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV" in a lesser frequency.

Most popular intervention types in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Maraviroc" (2 trials), "Emtricitabine/tenofovir" (1 trials), "Placebo" (1 trials), "darunavir/ritonavir 800/100 mg" (1 trials) and "placebo for emtricitabine/tenofovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinikum Bonn, Immunologische Ambulanz HIV". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitaetsklinikum Bonn, Immunologische Ambulanz HIV, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinikum Bonn, Immunologische Ambulanz HIV, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".